Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

NCT04061512 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG: Dexamethasone, cyclophosphamide, rituximab
DRUG: Rituximab, ibrutinib

Sponsor

University College, London

Collaborators

[object Object]